Review for "Superior HbA1c control with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with ≤50 units insulin degludec in Japanese subjects with type 2 diabetes in a phase 3, double‐blind, randomised trial"
Keyword(s):
Phase 3
◽